Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifecare ASA Director's Dealing 2025

Sep 26, 2025

3654_dirs_2025-09-26_8b1be705-eb5b-4fda-97a8-21ae876fa5e9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

LIFECARE ASA: MANDATORY NOTIFICATION OF TRADE

Please refer to the attached PDMR-form for details.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication at 2025-09-26 18:40 CEST.

Attachments

PDMR Attachment